Pembrolizumab-induced diffuse myositis in a patient of metastatic colon cancer: a case report

Clin Med (Lond). 2023 Nov;23(Suppl 6):15. doi: 10.7861/clinmed.23-6-s15.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects
  • Colonic Neoplasms* / drug therapy
  • Humans

Substances

  • pembrolizumab
  • Antibodies, Monoclonal, Humanized